Breast implant manufacturer Sientra’s headquarters in Goleta. The Securities and Exchange Commission has charged Goleta breast implant maker Sientra and its former CEO Hani Zeini with misleading investors in a 2015 stock offering that netted the company gross proceeds of $66 million. The company agreed to settle the charges without admitting or denying the findings,…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
